article · Diabetes Obesity and Metabolism

Efficacy and Safety of Olezarsen in Hypertriglyceridemia: An Updated Meta‐Analysis of Randomised Controlled Trials

Ahmed Emara
Heba Aboeldahab
Omar F. Abbas
Najat AlSejari
Amal A. Alsubaiei
Hamza A. Abdul‐Hafez
Hamad Salman Saif
Ahmed Mansour
Abdalhakim Shubietah
Ameer Awashra
Mohammed Mhanna

2026Al-Azhar University

Abstract

Olezarsen provides substantial triglyceride reduction with favourable effects on atherogenic lipoproteins and a tolerable short-term safety profile. Longer-term trials are needed to confirm cardiovascular outcomes and safety.

Research topics

Diabetes, Cardiovascular Risks, and Lipoproteins
Lipoproteins and Cardiovascular Health
Lipid metabolism and disorders

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1111/dom.70716

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.